Evoke Pharma Inc. held its Annual Meeting on May 21, 2025, via a live webcast. During the meeting, stockholders voted on several proposals. The election of Malcolm R. Hill, Pharm.D., and Vickie W. Reed to the Board of Directors was approved. The appointment of BDO USA, P.C. as the independent auditors for the year ending December 31, 2025, was ratified. The advisory vote on the frequency of future stockholder votes on executive compensation resulted in a recommendation for every three years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evoke Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-076374), on May 22, 2025, and is solely responsible for the information contained therein.